Patent details

Herbas

VPB

Print

EN | LT

LT - ANTIPSYCHOTIC TREATMENT BASED ON DRD2 OR ANKK1 SNP GENOTYPE

EN - ANTIPSYCHOTIC TREATMENT BASED ON DRD2 OR ANKK1 SNP GENOTYPE

Legal status

Patent not validated

Bibliographic data

Indications of the International Patent Classification (IPC)
(51)	INT.CL.	C12Q 1/68
		A61P 25/18

European patent
(11)	Number of the document	2430183
(13)	Kind of document	T
(96)	European patent application number	10719224.7
	Date of filing the European patent application	2010-05-15
(97)	Date of publication of the European application	2012-03-21
(45)	Date of publication and mention of the grant of the patent	2014-12-17
(46)	Date of publication of the claims translation

PCT application
(86)	Number	PCT/US2010/035045
	Date	2010-05-15

PCT application publication
(87)	Number	WO 2010/132866
	Date	2010-11-18

Priority applications
(30)	Number	Date	Country code
	178934 P	2009-05-15	US

Inventors
(72)	LAVEDAN, Christian, US VOLPI, Simona, US

Grantee
(73)	Vanda Pharmaceuticals Inc., 2200 Pennsylvania Avenue Suite 300-E, Washington, DC 20037, US

Title
(54)	ANTIPSYCHOTIC TREATMENT BASED ON DRD2 OR ANKK1 SNP GENOTYPE
	ANTIPSYCHOTIC TREATMENT BASED ON DRD2 OR ANKK1 SNP GENOTYPE